Vivos Inc. (RDGL)
OTCMKTS · Delayed Price · Currency is USD
0.1030
+0.0080 (8.42%)
Aug 22, 2025, 4:00 PM EDT
Vivos Employees
Vivos had 1 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$51,743
Profits / Employee
-$3,328,660
Market Cap
46.74M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1 | 0 | - |
Dec 31, 2023 | 1 | 0 | - |
Dec 31, 2022 | 1 | 0 | - |
Dec 31, 2021 | 1 | 0 | - |
Dec 31, 2020 | 1 | 0 | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 68 |
American Oncology Network | 1,914 |
CytoDyn | 13 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 116 |
Vivos News
- 9 days ago - Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Declined By FDA - GlobeNewsWire
- 5 weeks ago - Vivos Inc. Submitted the Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Clinic - GlobeNewsWire
- 3 months ago - Vivos Inc. Certifies University of Florida Veterinary Hospital for IsoPet® Precision Radionuclide Therapy™ - GlobeNewsWire
- 4 months ago - Vivos Inc. Achieves Record Growth in IsoPet® Animal Cancer Treatments in Q1 2025 - GlobeNewsWire
- 4 months ago - Vivos Inc. Reports Continued Progress in India Human Clinical Trial for RadioGel® Precision Radionuclide Therapy™ - GlobeNewsWire
- 8 months ago - Vivos Inc.'s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics Nationwide - GlobeNewsWire
- 8 months ago - Vivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical Trial - GlobeNewsWire
- 11 months ago - Vivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTM - GlobeNewsWire